-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Eli Lilly, Raises Price Target to $1232

Benzinga·06/25/2026 16:12:27
Listen to the news
Leerink Partners analyst David Risinger maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $1119 to $1232.